European Archives - Page 255 of 1188 - European Medical Journal

FDA nod for Johnson & Johnson’s atrial fibrillation device

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

Myocarditis Following COVID-19 Recovery

Research has revealed that myocarditis is a significant consequence of COVID-19, with over half of recovered patients showing cardiac injury through cardiac magnetic resonance imaging

Optimising Androgen Deprivation Therapy for Advanced Prostate Cancer

Androgen deprivation therapy has been the cornerstone of treatment for advanced castration-sensitive prostate cancer for over fifty years.

Distinct COVID-19 Clinical Phenotypes Identified in Hospitalised Children

New research identifies six clinical phenotypes in young COVID-19 patients, offering insights for personalised paediatric care.

Higher White-Matter Volume Linked to Mild Cognitive Impairment

MRI has shown that increases in the white matter of the brain and ventricle volume may be risk factors for the progression of mild cognitive impairment.

The Link Between Childhood Attention Issues, Genetics and Psychosis

Childhood attention issues, when combined with genetic predispositions, significantly increase the likelihood of experiencing psychotic-like symptoms in adolescence

Low-Dose Aspirin Linked to Increased Risk of Anaemia in Older Adults

A recent population-based cohort study from Denmark has found that low-dose aspirin (LDA) is significantly associated with an increased risk of anemia in older adults.

Benefits of Bariatric Surgery in Young Patients

Young people with obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss 10 years later.

Health Impacts of Incense Burning

A case study from ACAAI highlights the health risks of incense burning, particularly affecting respiratory health.

A hospital corridor

Pandemic Lessons and Vaccine Advocacy

This week, Jonathan is joined by Silvia Munoz-Price to discuss lessons from the COVID-19 pandemic, vaccine hesitancy, and health equity.